Effective adaptive immune responses require a large repertoire of naive T cells that migrate throughout the body, rapidly identifying almost any foreign peptide 1 . Because the production of T cells declines with age, naive T cells must be long-lived 2 . However, it remains unclear how naive T cells survive for years while constantly travelling. The chemoattractant sphingosine 1-phosphate (S1P) guides T cell circulation among secondary lymphoid organs, including spleen, lymph nodes and Peyer's patches, where T cells search for antigens. The concentration of S1P is higher in circulatory fluids than in lymphoid organs, and the S1P 1 receptor (S1P 1 R) directs the exit of T cells from the spleen into blood, and from lymph nodes and Peyer's patches into lymph 3 . Here we show that S1P is essential not only for the circulation of naive T cells, but also for their survival. Using transgenic mouse models, we demonstrate that lymphatic endothelial cells support the survival of T cells by secreting S1P via the transporter SPNS2, that this S1P signals through S1P 1 R on T cells, and that the requirement for S1P 1 R is independent of the established role of the receptor in guiding exit from lymph nodes. S1P signalling maintains the mitochondrial content of naive T cells, providing cells with the energy to continue their constant migration. The S1P signalling pathway is being targeted therapeutically to inhibit autoreactive T cell trafficking, and these findings suggest that it may be possible simultaneously to target autoreactive or malignant cell survival 4 .
of T cells in the LN of Spns2Δ mice compared to littermate controls ( Fig. 1b, Extended Data Fig. 1h ). Naive T cells were also not found in other tissues, and we saw little evidence of spontaneous activation or reduced homeostatic proliferation (Extended Data Figs 2d-h, 3) .
The one clear defect among naive T cells in LN of Spns2Δ mice was a doubling of the fraction of dying cells, measured by propidium iodide uptake or by staining with annexin V and a probe for active caspases ( Fig. 1c -e, Extended Data Fig. 1i-n) . We observed increased death in both Spns2Δ mice and Spns2Δ mice reconstituted with wild-type bone 1 Spleen **** *** marrow, but not in wild-type mice reconstituted with Spns2Δ bone marrow, implicating SPNS2 in lymphatic endothelial cells, as opposed to macrophages and other haematopoietic cells targeted by Lyve1-cre (Extended Data Fig. 4 ).
Although the increase in the rate of cell death was small, it might result in a substantial decline in numbers over time. If increased cell death accounted for the loss of naive T cells, preventing cell death should rescue cell recovery. To test this, we used BCL2 transgenic mice, which overexpress the human BCL2 gene and are resistant to the mitochondrial pathway of apoptosis 11 . We co-transferred T cells from BCL2 transgenic mice and wild-type littermates into Spns2Δ mice and littermate controls. Three weeks later, we measured cell recovery. Overexpression of BCL2 did not change the number of T cells recovered in control hosts. In addition, overexpression of BCL2 did not rescue T cell recovery from the spleen of Spns2Δ hosts, in which T cells are lost because they exit into blood and then become trapped in LN. However, while approximately 35% fewer wild-type cells were recovered from the LN of Spns2Δ mice compared to controls, approximately 60% more BCL2-transgenic T cells were recovered from the LN of Spns2Δ mice compared to controls. Upon inhibition of apoptosis, cells accumulated in the LN, as we had initially expected to see when cells were trapped there ( Fig. 1f , Extended Data Fig. 1o, p) .
There are many possible explanations for the increased T cell death; indeed, SPNS2 may transport more substrates than S1P. However, T cells in Spns2Δ mice no longer circulate, and the T cells are exposed to less S1P (they no longer sense S1P periodically in blood and lymph, or low levels of S1P within the LN parenchyma) 12 . We asked whether restoring S1P exposure without restoring circulation could rescue T cell survival. We treated Spns2Δ mice and littermate controls with 4-deoxypyridoxine (DOP), which inhibits the S1P-degrading enzyme S1P lyase. DOP increases extracellular levels of S1P in the LN of wild-type mice, and traps T cells in LN by flattening the S1P gradient that drives T-cell exit 13 . To confirm that DOP treatment also increased S1P levels in LN of Spns2Δ mice, we took advantage of the fact that S1P 1 R is internalized upon binding ligand 13, 14 . Surface levels of S1P 1 R were fivefold higher on T cells in vehicle-treated Spns2Δ mice than in littermate controls, reflecting lower exposure to S1P (Extended Data Fig. 5a -c). S1P 1 R was internalized on T cells in both DOP-treated control and Spns2Δ mice, indicating that S1P exposure had increased (Extended Data Fig. 5a-c) . In Spns2Δ mice, this was due to S1P secretion by cells not targeted by Lyve1-cre or SPNS2-independent secretion. DOP did not restore the S1P gradient required for exit, as there was no increase in the numbers of circulating T cells in DOP-treated compared to vehicletreated Spns2Δ mice (Extended Data Fig. 5d, e ). DOP treatment reduced T cell apoptosis and increased the recovery of transferred cells in Spns2Δ mice ( Fig. 2a -c, Extended Data Fig. 5f-h ). This suggested that S1P signalling, independent of a role in egress, supports the survival of T cells.
We next considered whether an S1P receptor controls T cell survival. Naive T cells express S1P 1 R and S1P 4 R, but we saw no loss of S1pr4 −/− T cells in LN (Extended Data Fig. 6 ). A role of S1P 1 R in T cell survival has not been addressed because S1pr1 −/− T cells do not leave the thymus 15, 16 . To test this, we bred mice in which S1pr1 could be inducibly deleted. We thymectomized adult S1pr1 f/f UBC-creER T2 mice (in which the human UBC promoter drives expression of tamoxifeninducible Cre recombinase) and littermate controls, then treated both groups with tamoxifen to delete S1pr1 and analysed the mice 12 weeks later. Like Spns2Δ mice, S1pr1-deficient mice (S1pr1Δ ; tamoxifentreated S1pr1 f/f UBC-creER T2 animals) had a reduction in the numbers of peripheral naive T cells and a higher frequency of dying naive T cells ( Fig. 3a, b , Extended Data Fig. 7a, b ). Mixed bone marrow chimaeras revealed that the survival defect was T-cell-intrinsic ( Fig. 3c, d , Extended Data Fig. 7c, d) . Consistent with a cell-intrinsic role for S1P 1 R, naive S1pr1Δ T cells isolated from mixed bone marrow chimaeras showed downregulation of transcripts associated with survival and upregulation of transcripts associated with death (Extended Data Fig. 7e ). DOP treatment of S1pr1Δ mice did not rescue cell death, suggesting that the restored T cell survival in DOP-treated Spns2Δ mice was probably mediated by S1P 1 R signalling (Extended Data Fig. 8 ).
We next asked how S1P 1 R signalling supports T cell survival. Two extrinsic factors are known to support T cell survival, IL-7 and self-peptide bound to major histocompatibility complex (MHC) [17] [18] [19] , but we found little evidence that S1P 1 R signalling regulates access to these (Extended Data Fig. 9 ). This seems unlike the role of CCL19-CCR7 signalling, which also supports T cell survival but does not have an additive effect with loss of IL-7 signalling in vivo 20 .
Naive T cells rely on oxidative phosphorylation, and decline in numbers following mitochondrial dysfunction 21 . We observed a reduction Spns2Δ mice and littermate controls were treated for 21 days with DOP or vehicle control. a, b, Frequency of PI + (a) and apoptotic (b) LN naive CD4 T cells. 5 groups, 3 experiments. c, Congenically marked BCL2-transgenic and littermate wild-type lymphocytes were co-transferred (1:1 by naive CD4 T cell counts). 21 days later, naive CD4 T cells were enumerated in LN of recipients. 10 groups, 4 experiments. †P = 0.078, * P < 0.05, * * P < 0.01, * * * P < 0.001, * * * * P < 0.0001, two-tailed unpaired t-test. , Adult S1pr1 f/f UBC-creER T2 mice and littermate controls were thymectomized, treated with tamoxifen, and analysed 12 weeks later. Number of naive CD4 T cells (a), and frequency of apoptotic naive CD4 T cells (b). 5 pairs, 3 experiments. c, d, CD45.1 + mice were reconstituted with a mix of bone marrow (BM) from wild-type UBC-GFP mice and either S1pr1 f/f UBC-creER T2 CD45.2 + mice or littermate controls. Chimaeras were thymectomized 6 weeks after reconstitution, and treated with tamoxifen 4 weeks later. c, Ratio of the number of S1pr1 f/f UBC-creER T2 or control naive CD4 T cells to GFP + naive CD4 T cells (GFP − :GFP + ). 5 pairs of mice from 2 bone marrow donor sets, analysed in 3 experiments 24 weeks after tamoxifen treatment (control spleen has 4 mice). d, Frequency of apoptotic naive CD4 T cells in LN. 10 pairs from 3 bone marrow donor sets in 5 experiments, analysed 12 or 24 weeks after tamoxifen treatment. * * P < 0.01, * * * * P < 0.0001, two-tailed unpaired t-test.
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in the levels of the mitochondrial proteins VDAC1 and COXIV in T cells from S1pr1Δ mice compared to littermate controls ( Fig. 4a, b ). We further observed a 40% decrease in staining for total mitochondria in S1pr1Δ T cells, and a similar decrease in staining for functional mitochondria using MitoTracker CMX-Ros, the accumulation of which depends on mitochondrial membrane potential ( Fig. 4c, d , Extended Data Fig. 10a ). S1pr1Δ T cells also had lower oxygen consumption rates (OCR) than littermate controls ( Fig. 4e , f, Extended Data Fig. 10f ). This decrease is unlikely to be secondary to cells undergoing apoptosis, because only a small fraction of cells are detectably apoptotic ( Fig. 3b ) and because T cells from BCL2 transgenic S1pr1Δ mice have a reduced rate of apoptosis (Extended Data Fig. 10b , c) but no increase in respiration ( Fig. 4f , Extended Data Fig. 10d-f ). T cells use both oxidative phosphorylation and aerobic glycolysis upon activation, and activated S1pr1Δ T cells proliferated less than controls when relying primarily on oxidative phosphorylation in medium containing galactose, but similarly to controls when able to perform glycolysis efficiently in the presence of glucose 21, 22 (Extended Data Fig. 10g -j). The loss of mitochondria seems to be specific, as we saw no reproducible decrease in the levels of endoplasmic reticulum (ER) protein calnexin or substantial evidence of ER stress, and the ratio of β -actin to total cell numbers was unchanged ( Fig. 4a , b, Extended Data Fig. 10k, l) . We observed increased deposition of ubiquitin on mitochondria in S1pr1Δ T cells, suggesting that mitochondrial loss may be due at least partly to mitophagy ( Fig. 4g, h) . Consistent with this, S1pr1Δ T cells had increased levels of PINK1, a kinase that accumulates upon mitochondrial dysfunction and induces the ubiquitination of mitochondrial proteins 23 ( Fig. 4i , j). These data suggest that S1P 1 R signalling is required in naive T cells to maintain mitochondrial content and function.
We identify S1P as an extrinsic factor that supports naive T cell survival, and suggest a role for lymphatic endothelial cells in regulating naive T cell numbers. Although S1P 1 R signalling is routinely described as being pro-survival, there has been little evidence to suggest that S1P 1 R is limiting in vivo because mice lacking S1P 1 R or both sphingosine kinases die at mid-gestation of haemorrhage 24, 25 , confounding attempts to study a cell-intrinsic role of S1P 1 R in survival. Studies of S1P 1 R in cultured cells are difficult to interpret because S1P in serum is an artificially dominant signal; in vivo, cells integrate signalling through multiple receptors sharing common downstream pathways. Consistent with previous reports, S1P induces AKT phosphorylation in T cells from LN, and future work will address whether this pathway regulates mitochondrial function 26 (Extended Data Fig. 10m ). The requirement of S1P 1 R for naive T cell survival, in the context of the many drugs being developed to target S1P 1 R signalling, points to the importance of assessing the requirement for S1P 1 R in lymphoma and central memory T cells. Given the energy cost of constant migration to sample antigen, use of the same cue that guides circulation to promote mitochondrial function is an efficient way for naive T cells to supply their required fuel.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 

METHODS
Mice. Spns2 f (ref. 5 ), S1pr1 f (ref. 27), S1pr4 (ref. 28), Lck-BCL2 transgenic 11 , Lyve1cre 10 , UBC-creER T2 (ref. 29), UBC-GFP 30 and MHCII-deficient 31 mice have been previously described. CD45.1 + congenic mice were obtained from Charles River Laboratories. All mice were on a C57BL/6 or C57BL/6-129 background. Mice were 5-52 weeks old at the time of analysis. Male and female mice were used depending on availability, as sex did not seem to affect the results. In all cases mice were compared to littermate controls. Mice were housed in specific pathogen-free conditions at the Skirball Institute animal facility. No animals were excluded from analysis unless they were clearly sick (hunched, low body weight). These criteria were pre-established, and are standard in the laboratory. No specific method of randomization was used to allocate mice into groups. The order of sample collection and data acquisition was designed to avoid experimental bias: collection and processing of samples from control and knockout, as well as treated and untreated animals, were alternated. No blinding was done, as there was no disease scoring. All animal experiments were performed in accordance with protocols approved by the New York University Institutional Animal Care and Use Committee. Mouse treatments. For bone marrow chimaeras, recipients were irradiated with two 6.5 Gy doses of γ -irradiation from a caesium source separated by 3 h, and received 2 × 10 6 -10 × 10 6 bone marrow cells by intravenous injection. Chimaeras were analysed at least 6 weeks after transplantation. Tamoxifen (approximately 75 mg kg −1 body weight) was administered intraperitoneally on 5 consecutive days. Unless otherwise indicated, analysis was 3 weeks after the last tamoxifen treatment. For adoptive transfer experiments, mice received spleen and lymph node lymphocytes including 1 × 10 6 -3 × 10 6 naive CD4 T cells in 0.1 ml by retro-orbital injection. For transfers into MHCII-deficient recipients, 1 × 10 6 -3 × 10 6 naive CD4 T cells were sorted and labelled with CellTrace Violet (Molecular Probes) according to the manufacturer's instructions before transfer. 4-deoxypyridoxine-HCl (DOP) treated mice received drinking water with 10 g l −1 sucrose plus 30 mg l −1 DOP (Sigma); vehicle-treated mice received drinking water with 10 g l −1 sucrose. Surgical removal of thymi was performed on intubated adult mice under 2% isoflurane using a ventilator (MiniVent Type 845, Harvard Apparatus). For antibody blockade experiments mice were injected intraperitoneally with 0.1 mg of antibodies and analysed 5 days after injection. For BrdU labelling, 1 mg BrdU (BD Biosciences) in sterile PBS was injected intraperitoneally every 24 h for 3 days, and mice were analysed 24 h after the last injection. Cell preparation. Lymphocytes were isolated from thymus, spleen, LN, Peyer's patches, lungs and liver by mechanical disruption and filtration through a 70-μ m cell strainer. LN were combined brachial, axillary, inguinal and mesenteric. Lymphocytes from the small intestinal lamina propria were isolated after removing the Peyer's patches. The tissue was minced with scissors and shaken vigorously for 1 min in HBSS. Minced intestines were further shaken at 100 r.p.m. for 30 min at 37 °C in HBSS containing HEPES (10 mM), sodium pyruvate (1 mM), EDTA (1 mM) and DTT (1 mM). Minced pieces were transferred to HBSS containing HEPES (10 mM), sodium pyruvate (1 mM) and EDTA (1 mM), and shaken at 100 r.p.m. for 10 min at 37 °C to remove the intestinal epithelial lymphocyte fraction (supernatant). Samples were further digested in 0.5 mg ml −1 collagenase D (Roche) and 0.1 mg ml −1 DNase I in HBSS, with shaking at 100 r.p.m. at 37 °C for 20 min. Digested samples were filtered through a 40-μ m strainer. Further purification of lymphocytes from the lungs, liver and lamina propia was performed by density gradient centrifugation using 40% and 80% Percoll (GE Healthcare). The cells at the interphase of the gradient were collected and washed twice.
Macrophages from LN were isolated by thorough mechanical disruption with scissors in HBSS. Minced LN were digested with collagenase IV (1 mg ml −1 , Sigma) with DNase I (0.2 mg ml −1 , Roche) for 20 min in HBSS at 37 °C with gentle rocking. Digested lymph node suspensions were passed through a 100-μ m cell strainer. Collagenase IV was inactivated with 5 mM EDTA and 10% FBS in PBS.
Further purification, as necessary, was either by magnetic bead enrichment (Stem Cell Technologies, biotin selection kit, used according to the manufacturer's instructions) or by flow cytometry (Beckman Coulter MoFlo or BD Biosciences FACSAria). Lymphocytes were enumerated with a cell counter (Beckman Coulter Multisizer 3) set to detect nuclei between 3.5 and 7 μ m. Antibodies. Antibodies to B220 (clone RA3-6B2), CD4 (clone RMA4-5 or GK1.5), CD8 (clone 53-6.7), CD62L (clone MEL14), CD69 (clone H1.2F3), IL-7Rα (clone A7R34), CD44 (clone IM7), Nur77 (clone 12.14), LYVE1 (clone ALY7), MHCII (clone M5/114.12.2), gp38 (clone 8.1.1), CD25 (clone PC61), PINK1 (clone 5E1. D8) and rat IgG2a-κ isotype control (clone RTK2758) were purchased from Biolegend, eBiosciences or BD Biosciences. Anti-S1P 1 R (clone 713412) was purchased from R&D Systems. Anti-pSTAT5 (clone D47E7), anti-AKT (catalogue number 9272), anti-pAKT (clone D9E), anti-S6 (clone 5G10) and anti-pS6 (clone D57.2.2E) antibodies were purchased from Cell Signaling Technologies. Anti-VDAC1 (clone 20B12AF2) and anti-COXIV (clone 20E8C12) were purchased from Abcam. Polyclonal anti-calnexin antibody (catalogue number A303-696A) was purchased from Bethyl Laboratories. Polyclonal anti-STAT5 (catalogue number C-17) and anti-β -actin (clone C4) antibodies were purchased from Santa Cruz Biotechnology. Anti-ubiquitin antibody (clone FK2) was purchased from Enzo Life Sciences. Blocking IL-7Rα (clone A7R34) 32 and isotype control (clone 2A3) antibodies were purchased from Bioxcell. Annexin V and propidium iodide were purchased from Biolegend. The CaspACE FITC-VAD-FMK probe for active caspases was purchased from Promega. For flow cytometry, cells were analysed using an LSRII (BD Biosciences); data were analysed using FlowJo version 8.8.1 (Tree Star). Mitochondrial labelling. Mitochondria were stained using MitoTracker Red CMXRos and MitoTracker Deep Red FM (Life Technologies) according to the manufacturer's instructions. In brief, cells (10 6 cells in 50 μ l) were incubated in 2% FBS and 1 mM EDTA in PBS containing 0.5 μ M MitoTracker dyes along with antibodies for staining cell surface makers for 20 min at 37 °C. After washing, cells were analysed using an LSRII (BD Biosciences) or further stained before analysis by confocal microscopy (LSM710; Carl Zeiss). Microscopy. Confocal imaging was done using standard conditions. In brief, LN were excised, fixed for 1 h at room temperature in 4% paraformaldehyde, and progressively dehydrated at 4 °C in sucrose (10%, 20% and 30% in PBS). Tissues were snap-frozen in OCT compound (Sakura Tissue-Tek). 8-μ m tissue sections were cut, rehydrated (rehydration and staining buffer was PBS with 4% mouse serum, 4% rat serum, 10 μ g ml −1 anti-CD16/32, 0.1% Triton X-100), stained and imaged. Sorted naive CD4 T cells stained with mitochondrial dyes were adhered to slides by cytospin and fixed in 4% paraformaldehyde for 15 min at room temperature. For ubiquitin stain, cells were permeabilized in 0.1% Triton X-100 for 5 min and blocked in 5% casein in PBS for 1 h at room temperature, followed by antibody staining in 0.1% Triton X-100 with 2% BSA. Nuclei were labelled with DAPI (2 μ g ml −1 ). Cells were imaged in mounting media (Life Technologies). All images were acquired using a confocal microscope (LSM710; Carl Zeiss) with a 25× or 63× oil immersion objective. Images were processed and analysed using ImageJ software (version 1.41; National Institutes of Health). Colocalization analysis and code availability. To calculate ubiquitin colocalization with mitochondria, pixels positive for the MitoTracker stain were identified, and for each MitoTracker + pixel the ratio of ubiquitin intensity to MitoTracker intensity was calculated. This ratio was averaged over three z-slices per cell. Each point on the graph represents one cell. The colocalization program (ImageJ software, version 1.41, National Institutes of Health) used to analyse ubiquitin deposition on mitochondria is provided in the Supplementary Information. In vitro survival assay. Sorted naive T cells were plated at a density of 10 6 cells per well in 24-well plates and were cultured at 37 °C in RPMI 1640 medium containing HEPES (10 mM) pH 7.2, penicillin (50 IU ml −1 ), streptomycin (50 μ g ml −1 ), β -mercaptoethanol (50 μ M), 10% FBS and IL-7 (0.01-10.0 ng ml −1 ) (Peprotech). After 5 days, cells were collected, stained with propidium iodide (Biolegend), and analysed by flow cytometry. T cell activation. Freshly isolated T cells from LN were stained for 20 min at 37 °C with 5 μ M CellTrace Violet (Molecular Probes/ThermoFisher) in PBS with 0.1% BSA. 4 × 10 5 T cells were plated in each well of a 48-well plate, pre-coated with 4 μ g ml −1 anti-CD3 (clone 145-2C11), in activation medium containing 2 μ g ml −1 anti-CD28 (clone 37.51). Activation medium contained glucose-free RPMI 1640 (Gibco) with 10% dialysed fetal bovine serum (Gibco), 2 mM glutamine (Mediatech), non-essential amino acids (Hyclone), 1 mM sodium pyruvate (Hyclone), and 55 μM 2-mercaptoethanol (Invitrogen), supplemented with either glucose (2 g l −1 ) or galactose (2 g l −1 ). After 72 h, cells were counted and CellTrace Violet dilution was assayed by flow cytometry. Western blot. Cells were lysed in RIPA buffer containing phosphatase and protease inhibitor cocktails (Roche). Lysates were resolved by SDS-PAGE followed by western blot using horseradish peroxidase (HRP)-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) and SuperSignal West Pico Chemiluminescent Substrate or SuperSignal West Femto Maximum Sensitivity Chemiluminescent Substrate (Thermo Scientific). Signal was detected using a Chemidoc MP System and quantified using Image Laboratory software (Bio-Rad Laboratories); there were no saturated pixels in any quantified images. For IL-7 stimulation, CD4 + T cells were isolated from LN and stimulated ex vivo with IL-7 (Peprotech) for 5 min at 37 °C. For S1P stimulation, CD4 T cells were isolated from LN and incubated ex vivo with 1 μ M S1P (Sigma) for 3 h at 37 °C. The cytoplasmic fraction was isolated using NE-PER nuclear and cytoplasmic extraction reagents (Thermo Scientific), according to the manufacturer's instructions. RNA-seq. Total RNA was extracted from samples using the RNeasy Plus Mini kit (Life Technologies). Samples were then subject to poly(A) selection using oligo-dT beads (Life Technologies) according to the manufacturer's instructions. RNA samples were used as input for library construction using TotalScript RNA-Seq Kit (Epicentre) according to the manufacturer's instructions. RNA libraries were sequenced on an Illumina HiSeq 2500 (HiSeq Single Read 50 Cycle Lane). Raw sequencing data passed quality control checks performed using FastQC (version 0.11.3). Sequenced reads were aligned to the mouse genome (version mm10 from UCSC) using STAR (version 2.4). Aligned reads were then quantified using HTSeq (version 0.6.0) for raw counts and CuffLinks (version 2.2.1) for fragments per kilobase of transcript per million mapped reads (FPKM) against the UCSC mm10 reference annotation. Initial expression data clustering revealed a batch effect due to variation between experimental days. The expression was corrected for batch effects using R package ComBat (Bioconductor Release 3.3) and a two-factor analysis for genotype and experimental day. R package Limma (Bioconductor Release 3.3) was used to identify differentially expressed genes. Genes significantly differentially expressed with a Benjamini-Hochberg adjusted P < 0.05 (false discovery rate (FDR) = 0.05) were selected. Pathway analysis on these genes was performed using ingenuity pathway analysis (IPA) (Qiagen, version 1.0). We show genes that fall into the IPA 'Molecular and cellular functions' category, with the annotation 'Cell death and survival' . Heat maps were created using batch-corrected expression values that were log-normalized (log 2 [expression + 1]) using ggplot2 library in R (Bioconductor Release 3.3). Mitochondrial function. Mitochondrial function of sorted naive T cells was assessed using Seahorse XF Cell Mito Stress Test Kit (Agilent Technologies) according to the manufacturer's instructions. In brief, sorted naive T cells were plated in Seahorse XF Base Medium supplemented with 1 mM pyruvate, 2 mM glutamine and 10 mM glucose (pH 7.4) in Seahorse XF96 Cell Culture microwell plates coated with CellTak (Corning). Cells were incubated for 45 min at 37 °C without CO 2 before running the assay. Samples were then run on a Seahorse XF e 96 Extracellular Flux Analyzer (Agilent Technologies) using the Seahorse XF Cell Mito Stress Test kit with 1 μ M oligomycin, 1 μ M carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), and 0.5 μ M rotenone/antimycin A. All samples were run in duplicate or triplicate. Equivalent cell numbers per sample were confirmed postrun by analysing DNA content. RT-qPCR. Total RNA was extracted from sorted cell populations using TRIzol (Invitrogen) according to the manufacturer's instructions. Before reverse transcription, RNA was treated with DNase I (Invitrogen). The RNA was converted to cDNA with Invitrogen's Superscript III First Strand Synthesis System according to the manufacturer's instructions, using a mix of oligo dT and random hexamers as primers. Quantitative PCR (qPCR) was performed on a Roche Light-Cycler 480 using iQ SYBR Green Supermix (Bio-Rad) according to the manufacturer's instructions. Primer pairs used were: Hprt F 5′ -AGGTTGCAAGCTTGCTGGT-3′ , Hprt R 5′ -TGAAGTACTCATTATAGTCAAGGGCA-3′; Eif2ak3 F 5′-GTGC TTACAGTGGAAAGCTGAG-3′ , Eif2ak3 R 5′ -GAAGTTCAAAGTGGCCA ACACT-3′ ; Hspa5 F 5′ -CTGCTGAGGCGTATTTGGGA-3′ , Hspa5 R 5′ -GCAG CTGCTGTAGGCTCATT-3′ ; Ddit3 F 5′ -GGAACCTGAGGAGAGAGTGTTC-3′ , Ddit3 R 5′ -CGTCTCCAAGGTGAAAGGCA-3′ .
To control for DNA contamination, a reaction without reverse transcriptase was performed in parallel for each sample/primer pair. To control for nonspecific amplification, the size of the reaction products was analysed by agarose gel electrophoresis. Primer pairs were tested for linear amplification over two orders of magnitude. 
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Extended Data Figure 1 | SPNS2 is required in lymphatic endothelial cells for peripheral T cell circulation. a, Diagram of distribution of naive T cells in the periphery of Spns2Δ mice and controls. Spns2Δ mice have normal plasma S1P and lymphocytes exit from the spleen into blood as usual, but in Spns2Δ mice lymph S1P is lost and egress from LN is blocked. Over time, this leads to a redistribution of T cells from the spleen to the LN and a loss of circulating cells, because any cell that leaves the spleen and enters a lymph node is trapped. b, Representative surface S1P 1 R on naive CD4 + T cells in the blood and spleen (top) and in the lymph and LN (bottom) of a Spns2Δ mouse and its littermate control. Surface S1P 1 R on T cells is internalized upon binding S1P. Hence the lower S1P 1 R on the surface of T cells in blood than in spleen, in both Spns2Δ and control animals, indicates that T cells sense more S1P in blood than in spleen. S1P 1 R is also lower on the surface of T cells in lymph than LN of control mice. But in Spns2Δ mice, S1P 1 R is equally high on T cells in lymph and LN, suggesting that the gradient that directs T cell exit from LN has been ablated. c-h, T cell distribution in Spns2Δ mice and littermate controls. There is no statistically significant difference in the death of naive CD4 or CD8 T cells in the spleen of Spns2Δ mice compared to littermate controls, although there seems to be a trend towards increased death in Spns2Δ mice. Normal T cell survival in the spleen of Spns2Δ mice is consistent with normal blood S1P and normal S1P production by blood vessel endothelial cells lining the marginal sinus, which probably maintain normal S1P 1 R signalling in T cells in the spleen. We hypothesize that the few T cells able to leave the LN of Spns2Δ mice are relatively healthy, and stabilized while they are in the spleen. However, we hesitate to overinterpret these results because very few T cells remain in the spleen of Spns2Δ animals, and they may be different in a way that is not captured by gating on CD62L hi CD44 lo T cells. o, p, Congenically labelled lymphocytes from BCL2-transgenic and wild-type littermate donors were co-transferred (1:1 by naive CD4 T cell counts) to Spns2Δ mice and littermate controls. Number of wild-type or BCL2-transgenic naive CD8 T cells recovered in spleen and LN 21 days after transfer. 9 pairs of mice analysed in 3 experiments. Lines indicate mean. * P < 0.05, * * P < 0.01, * * * P < 0.001 * * * * P < 0.0001, unpaired two-tailed t-test. 
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Blood Figure 5 | Naive T cell survival is dependent on S1P, but independent of circulation. Spns2Δ mice and littermate controls were treated for 21 days with 30 mg l −1 DOP and 10 g l −1 sucrose, or sucrose alone, in the drinking water. a-c, The effect of DOP treatment on T cell exposure to extracellular S1P within the LN was assessed by measuring surface expression of S1P 1 R on naive T cells, which is inversely related to S1P levels. a, Representative flow cytometry plot of surface S1P 1 R on naive CD4 T cells. An FTY720-treated mouse was used as a negative control for S1P 1 R staining. b, Ratio of cell surface S1P 1 R MFI on naive CD4 T cells from LN of the indicated mice to cell surface S1P 1 R MFI on naive CD4 T cells from LN of sucrose-treated control mice. 5 groups of mice analysed in 5 experiments. c, Ratio of cell surface S1P 1 R MFI on naive CD8 T cells from LN of the indicated mice to cell surface S1P 1 
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